Skip to content

King Pharmaceuticals KG Workers' Compensation — Year 1

Other product segments

All other lines
57%
International
41.8%
Commercial Auto Liability
11.9%
General Liability
5.9%
European Hospital Liability
3.2%

Similar metrics at other companies

Old Republic International logo
ORIWorkers' Compensation — Year 1
16.8%+0.3pp
CNA Financial logo
CNAWorkers' Compensation — Year 1
17.6%+0.8pp
The Hartford Financial Services Group logo
HIGWorkers' Compensation — 1st Year
14.9%+0.1pp
United Fire Group logo
UFCSCommercial workers' compensation — Year 1
34.4%+1.5pp
Old Republic International logo
ORIWorkers' Compensation — Year 2
24.1%-0.2pp
CNA Financial logo
CNAWorkers' Compensation — Year 2
24.2%+0.8pp

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-67.6%
Enterprise value$184.93M-50.0%
P/E1.2×
P/S1.6×-24.3×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's workers' compensation — year 1.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's workers' compensation — year 1?
King Pharmaceuticals (KG) reported workers' compensation — year 1 of 19.2% in Q4 2025.
What does workers' compensation — year 1 mean?
This metric represents the financial performance or claim activity specifically associated with the first year of the workers' compensation policy cycle. It is used to analyze the initial loss development patterns and underwriting results for the most recent cohort of business. Comparing this across years helps identify trends in early-stage claim frequency and severity.